在心力衰竭中,B型尿素的变化和左心室重塑动力学与减少喷射分数的心力衰竭
Erick Romero1, Yevhen Kushnir1, Daniel Mendoza-Quispe1
1St. Barnabas Hospital, SBH Health System, City University of New York (CUNY) School of Medicine, Bronx, NY.
medRxiv : the preprint server for health sciences
|November 19, 2025
概括
降低B型尿素 (BNP) 在心力衰竭中降低排泄率 (HFrEF) 患者的水平与改善左心室 (LV) 几何和降低死亡率相关. 上升的BNP表明LV重塑恶化和较高的死亡风险.
科学领域:
- 心脏病学 心脏病学
- 生物标志物 生物标志物
- 心脏衰竭研究研究
背景情况:
- B型尿素 (BNP) 是心力衰竭的关键生物标志物,具有减少喷射率 (HFrEF).
- 了解BNP动态对于管理HFrEF和预测结果至关重要.
- 长期的BNP变化及其与左心室 (LV) 几何学的关联需要进一步研究.
研究的目的:
- 探索HFrEF患者的BNP水平变化与LV几何学的长期动态之间的关系.
- 为了研究BNP变化三角形和LV重塑参数之间的关联.
- 评估BNP变化对HFrEF所有原因死亡率的影响.
主要方法:
- 887名HFrEF患者的回顾性队列研究,基线和随后的BNP测量.
- 患者根据百分比的BNP变化被分为三级:下降,最小变化和上升.
- 主要终点包括LV内部尺寸 (LVIDs,LVIDd) 和LV喷射率 (LVEF) 的变化;次要终点是全因死亡率.
主要成果:
- 在BNP变化三位体中观察到基线特征的显著变化.
- 与BNP上升的患者相比,BNP下降的患者表现出改善的LV几何,包括减少的LVID和LVIDd,以及增加的LVEF.
- 与下降的BNP tertile相比,不断上升的BNP tertile显示出更高的全因死亡率.
结论:
- 在HFrEF中,BNP变化与LV重塑动态和生存有时间依赖的关系.
- 这些发现支持BNP作为反映LV重塑过程的动态标记物的实用性.
- 监测BNP趋势为HFrEF的预测和指导管理策略提供了宝贵的见解.
相关概念视频
01:29Heart Failure II: Pathophysiology
693
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
693
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
895
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
895
01:17Pathophysiology of Heart Failure
2.7K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.7K
01:30Heart Failure V: Medical Management
204
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
204
01:20Mitral Regurgitation I: Introduction
392
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
392
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
522
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
522